Pharmaceutical - Pharmaceutical, GSK

Filter

Current filters:

PharmaceuticalGSK

Popular Filters

Jack Bailey to replace Deirdre Connelly as US pharma head at GSK

Jack Bailey to replace Deirdre Connelly as US pharma head at GSK

17-02-2015

UK pharma major GlaxoSmithKline has named Jack Bailey as president of its US pharma unit.

BoardroomGSKPharmaceuticalUnited StatesUSA

Positive overall survival rates for GSK's Tafinlar/Mekinist combination

Positive overall survival rates for GSK's Tafinlar/Mekinist combination

06-02-2015

UK pharma major GlaxoSmithKline has announced positive overall survival rates from the Phase III study…

GSKMekinistOncologyPharmaceuticalResearchTafinlar

Ablynx successfully opposes Domantis' European patent appeal

Ablynx successfully opposes Domantis' European patent appeal

22-01-2015

Belgian drug developer Ablynx has successfully opposed the appeal lodged by Domantis over its European…

AblynxEuropeGSKLegalPharmaceutical

ORCHID project aims to slash development time of tuberculosis drugs

ORCHID project aims to slash development time of tuberculosis drugs

14-01-2015

A collaborative project led by a scientist from UK pharma major GlaxoSmithKline has identified new compounds…

Antibiotics and Infectious diseasesGSKIsoniazidPharmaceuticalResearch

Sources say GSK to cut hundreds of jobs in the US following oncology business sale to Novartis

Sources say GSK to cut hundreds of jobs in the US following oncology business sale to Novartis

01-12-2014

Sources close to the company have said UK pharma major GlaxoSmithKline is to announce hundreds of job…

AdvairGSKOncologyPharmaceuticalProductionSocial IssuesUSA

Early results from GSK and NIH's Phase I Ebola vaccine show promise

Early results from GSK and NIH's Phase I Ebola vaccine show promise

27-11-2014

UK pharma major GlaxoSmithKline has reported promising preliminary results from a small Phase I trial…

Anti-viralsEbola vaccineGSKPharmaceuticalResearch

GSK COPD survey shows many sufferers underestimate the severity of their condition

GSK COPD survey shows many sufferers underestimate the severity of their condition

12-11-2014

UK pharma major GlaxoSmithKline has conducted a global survey of people living with chronic obstructive…

GlobalGSKPharmaceuticalResearchRespiratory and PulmonaryUnited States

UK's NICE recommends GSK's Arzerra for untreated chronic lymphocytic leukemia

UK's NICE recommends GSK's Arzerra for untreated chronic lymphocytic leukemia

04-11-2014

The UK’s National Institute for Health and Care Excellence has issued new preliminary draft guidance…

ArzerraGSKOfatumumab InjectionOncologyPharmaceuticalRegulationUK

Genmab transfers its ofatumumab collaboration from GSK to Novartis

Genmab transfers its ofatumumab collaboration from GSK to Novartis

03-11-2014

Danish biotech company Genmab has entered into an agreement with UK pharma major GlaxoSmithKline and…

DenmarkGenmabGSKNovartisOfatumumab InjectionOncologyPharmaceuticalResearch

Safety trials under way for GSK and Canadian Public Health Agency's Ebola vaccines

Safety trials under way for GSK and Canadian Public Health Agency's Ebola vaccines

27-10-2014

Safety trials are currently under way in two of the most advanced Ebola candidates, and the World Health…

Antibiotics and Infectious diseasesGSKPharmaceuticalResearchUKUSA

Saudi Arabian pharma needs to reconsider its business proposition to compete with global giants

Saudi Arabian pharma needs to reconsider its business proposition to compete with global giants

14-10-2014

The Saudi Arabian pharma market is a changing landscape in the face of the physical penetration of international…

GSKMarkets & MarketingPfizerPharmaceuticalSaudi Arabia

ERS 2014: GSK reports positive Phase III results of its mepolizumab in asthma

ERS 2014: GSK reports positive Phase III results of its mepolizumab in asthma

08-09-2014

UK pharma major GlaxoSmithKline has reported positive data from its Phase III asthma studies of mepolizumab,…

GlaxoSmithKlineGSKImmunosuppressantsmepolizumabMepolizumabPharmaceuticalResearchRespiratory and PulmonaryUK

GSK and Genmab announce positive interim results for ofatumumab Phase III

GSK and Genmab announce positive interim results for ofatumumab Phase III

01-08-2014

UK Pharma major GlaxoSmithKline and Danish biotechnology company Genmab have said that an interim analysis…

Chronic lymphocytic leukemiaDenmarkGenmabGSKOfatumumabOfatumumab InjectionOncologyPharmaceuticalRafael AmadoResearchUK

Trametinib and dabrafenib gives overall survival benefit compared to vemurafenib

Trametinib and dabrafenib gives overall survival benefit compared to vemurafenib

17-07-2014

GlaxoSmithKline says that the Independent Data Monitoring Committee (IDMC) has recommended a Phase III…

BRAFdabrafenibGlobalGSKMetastatic cutaneous melanomaOncologyPharmaceuticalResearchtrametinibvemurafenib

GSK spies indicted in China for illegally obtaining information

GSK spies indicted in China for illegally obtaining information

15-07-2014

A couple allegedly working for UK pharma major GlaxoSmithKline in China have been indicted in Shanghai…

ChinaGlaxoSmithKlineGSKLegalPharmaceuticalXinhua News AgencyXinhua News Agency

ADA 2014: GSK presents new data for once-weekly Tanzeum in type 2 diabetes

ADA 2014: GSK presents new data for once-weekly Tanzeum in type 2 diabetes

15-06-2014

Patients enrolled in of four randomized Phase III studies who remained on Tanzeum/Eperzan (albiglutide),…

Anti-diabetic drugsDiabetesGlaxoSmithKlineGSKMajorPharmaceuticalResearchStudy protocolStudy protocolTanzeumUK

GSK faces fresh allegations of “inproper conduct” in Iraq

GSK faces fresh allegations of “inproper conduct” in Iraq

08-04-2014

UK pharma major GlaxoSmithKline is facing allegations of bribery in Iraq, less than a year after the…

ChinaGlaxoSmithKlineGSKIraqMajorPharmaceuticalRegulationUK

NHS England approves GSK’s Tafinlar for funding by UK’s Cancer Drugs Fund

NHS England approves GSK’s Tafinlar for funding by UK’s Cancer Drugs Fund

04-02-2014

GlaxoSmithKline’s Tafinlar (dabrafenib) is now available for metastatic melanoma patients in England…

FinancialGSKOncologyPharmaceuticalRegulationTafinlarUK

GSK stock will remain strong despite slowing emerging markets, say analysts

GSK stock will remain strong despite slowing emerging markets, say analysts

04-10-2013

Following concerns from Eli Lilly about the slowdown of emerging markets and devaluation of the Japanese…

EuropeFinancialGlaxoSmithKlineGSKPharmaceutical

Skyepharma's asthma drug helps revenues soar 58% in first half

15-08-2013

UK drug delivery specialist Skyepharma (LSE: SKP) has seen its first half revenues soar 58% to £31.3…

EuropeFinancialFlutiformGSKPharmaceuticalSkyepharma

GSK inks $300m rare diseases alliance with Angiochem

28-02-2012

GlaxoSmithKline has forged an R&D alliance with Montreal, Canada-based Angiochem that will focus on the…

AngiochemCerezymeGenzymeGSKNeurologicalPharmaceuticalRare diseasesShireVpriv

COMPANY SPOTLIGHT

Menarini

Back to top